Long-term cardiovascular risk of white-coat hypertension with normal night-time blood pressure values

被引:7
|
作者
Faria, Joao [1 ]
Mesquita-Bastos, Jose [2 ]
Bertoquini, Susana [3 ]
Silva, Jose [3 ]
Barbosa, Loide [3 ]
Polonia, Jorge [1 ]
机构
[1] Univ Porto, Fac Med, Dept Med & Cintesis, Porto, Portugal
[2] Aveiro Univ, Hlth Sch, Aveiro, Portugal
[3] ULS, Hosp Pedro Hispano, Hypertens Unit, Matosinhos, Portugal
关键词
cardiovascular events; normal night-time blood pressure; white-coat hypertension; MASKED HYPERTENSION; COST-EFFECTIVENESS; PROGNOSTIC VALUE; PRIMARY-CARE; EVENTS; STROKE; PREVALENCE; DISEASES;
D O I
10.1097/MBP.0000000000000364
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background The prognostic impact of white-coat hypertension (WCHT) is still a matter of debate and controversy. Night-time blood pressure (NBP) is related strongly to cardiovascular (CV) prognosis, but this has not been considered currently in the definition of WCHT. Patients and methods We investigated the long-term CV prognosis of 2659 patients submitted at admission to 24 h-ambulatory blood pressure (BP) monitoring divided into three groups: normotension (NT) (n=812; 59% female; ageing 49 +/- 13 years), sustained hypertension (SHT) (n=1230; 56% female; ageing 51 +/- 13 years) and WCHT (n=617; 55% female; ageing 50 +/- 3 years) defined as office BP of at least 140/90 mmHg, daytime BP less than 135/85 mmHg and NBP less than 120/70 mmHg. Results The median follow-up was 7.6 years (range: 0.4-24.4), during which a total of 257 CV events (36 fatal) occurred (46% strokes, 32% coronary and 22% others), 38 in NT, 31 in WCHT and 188 in SHT. The event rate per 100 patient-years was 0.60 in the WCHT group, 0.66 in the NT group and 2.09 in the SHT group. Cox's regression analysis adjusted for covariables showed a higher risk of CV events in patients with SHT than WCHT [hazard ratio (HR)=2.230, 95% confidence interval: 1.339-3.716, P=0.002], whereas there was no difference between WCHT and NT groups. Event-free survival was significantly different from SH versus WCHT and NT groups. Within the group of WCHT, 29% of patients received sustained antihypertensive medication during the follow-up, but the HR of CV events between WCHT either treated or not treated did not differ: HR=0.76 (95% confidence interval: 0.37-1.51, P=0.42). Conclusion In patients with WCHT defined by normal daytime and NBP values, the risk of CV events was significantly lower than that of SHT and similar to that of NT patients, suggesting that NBP should be included in the WCHT definition and in its prognostic stratification.
引用
收藏
页码:59 / 66
页数:8
相关论文
共 50 条
  • [1] Long-Term Risk of Progression to Sustained Hypertension in White-Coat Hypertension with Normal Night-Time Blood Pressure Values
    Faria, Joao
    Bastos, Jose Mesquita
    Bertoquini, Susana
    Silva, Jose
    Polonia, Jorge
    INTERNATIONAL JOURNAL OF HYPERTENSION, 2020, 2020
  • [2] LONG-TERM RISK OF CARDIOVASCULAR EVENTS IN WHITE-COAT HYPERTENSION DEFINED BY DAYTIME AND NIGHTTIME BLOOD PRESSURE LIMITS
    Faria, J.
    Bertoquini, S.
    Silva, J.
    Barbosa, L.
    Polonia, J.
    JOURNAL OF HYPERTENSION, 2017, 35 : E23 - E23
  • [3] Long-Term Risk in Subjects With White-Coat Hypertension
    Obara, Taku
    Ohkubo, Takayoshi
    Imai, Yutaka
    HYPERTENSION, 2009, 54 (05) : E133 - E133
  • [4] Short- and long-term risk of cardiovascular events in white-coat hypertension
    S D Pierdomenico
    D Lapenna
    R Di Mascio
    F Cuccurullo
    Journal of Human Hypertension, 2008, 22 : 408 - 414
  • [5] Short- and long-term risk of cardiovascular events in white-coat hypertension
    Pierdomenico, S. D.
    Lapenna, D.
    Di Mascio, R.
    Cuccurullo, F.
    JOURNAL OF HUMAN HYPERTENSION, 2008, 22 (06) : 408 - 414
  • [6] Long-Term Risk of Sustained Hypertension in White-Coat or Masked Hypertension
    Mancia, Giuseppe
    Bombelli, Michele
    Facchetti, Rita
    Madotto, Fabiana
    Quarti-Trevano, Fosca
    Friz, Hernan Polo
    Grassi, Guido
    Sega, Roberto
    HYPERTENSION, 2009, 54 (02) : 226 - 232
  • [7] Long-Term Risk in Subjects With White-Coat Hypertension Response
    Mancia, Giuseppe
    Bombelli, Michele
    Facchetti, Rita
    Madotto, Fabiana
    Quarti-Trevano, Fosca
    Friz, Hernan Polo
    Grassi, Guido
    Sega, Roberto
    HYPERTENSION, 2009, 54 (05) : E134 - E134
  • [8] The Cardiovascular Risk of White-Coat Hypertension
    Franklin, Stanley S.
    Thijs, Lutgarde
    Asayama, Kei
    Li, Yan
    Hansen, Tine W.
    Boggia, Jose
    Jacobs, Lotte
    Zhang, Zhenyu
    Kikuya, Masahiro
    Bjorklund-Bodegard, Kristina
    Ohkubo, Takayoshi
    Yang, Wen-Yi
    Jeppesen, Jorgen
    Dolan, Eamon
    Kuznetsova, Tatiana
    Stolarz-Skrzypek, Katarzyna
    Tikhonoff, Valerie
    Malyutina, Sofia
    Casiglia, Edoardo
    Nikitin, Yuri
    Lind, Lars
    Sandoya, Edgardo
    Kawecka-Jaszcz, Kalina
    Filipovsky, Jan
    Imai, Yutaka
    Wang, Ji-Guang
    O'Brien, Eoin
    Staessen, Jan A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (19) : 2033 - 2043
  • [9] NOCTURNAL BLOOD PRESSURE DIPPING STATUS AND CARDIOVASCULAR RISK IN WHITE-COAT HYPERTENSION INDIVIDUALS
    Liakos, C.
    Karpanou, E.
    Grassos, C.
    Markou, M.
    Vyssoulis, G.
    Tousoulis, D.
    JOURNAL OF HYPERTENSION, 2019, 37 : E10 - E10
  • [10] Effect of Long-Term Antihypertensive Treatment on White-Coat Hypertension
    Mancia, Giuseppe
    Facchetti, Rita
    Parati, Gianfranco
    Zanchetti, Alberto
    HYPERTENSION, 2014, 64 (06) : 1388 - U467